Guhan Pharmaceutical Group Co., Ltd. (SHE:000590)
12.23
-0.11 (-0.89%)
Mar 11, 2026, 3:04 PM CST
SHE:000590 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 10, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 2,955 | 1,703 | 2,146 | 2,141 | 2,366 | 2,031 | Upgrade
|
| Market Cap Growth | 69.74% | -20.65% | 0.22% | -9.51% | 16.51% | -29.10% | Upgrade
|
| Enterprise Value | 2,877 | 1,625 | 2,045 | 1,954 | 2,022 | 1,680 | Upgrade
|
| Last Close Price | 12.34 | 7.11 | 8.96 | 8.94 | 9.88 | 8.48 | Upgrade
|
| PE Ratio | - | - | 84.99 | 118.22 | 66.76 | 89.37 | Upgrade
|
| Forward PE | - | 91.43 | 91.43 | 91.43 | 91.43 | 91.43 | Upgrade
|
| PS Ratio | 8.40 | 4.96 | 5.30 | 6.11 | 7.87 | 7.38 | Upgrade
|
| PB Ratio | 5.04 | 2.83 | 2.95 | 3.05 | 3.47 | 3.15 | Upgrade
|
| P/TBV Ratio | 6.65 | 3.75 | 4.67 | 5.30 | 4.33 | 4.01 | Upgrade
|
| P/FCF Ratio | - | - | - | 59.82 | - | 115.55 | Upgrade
|
| P/OCF Ratio | 80.71 | 97.92 | - | 39.30 | 93.90 | 39.45 | Upgrade
|
| EV/Sales Ratio | 8.18 | 4.74 | 5.05 | 5.57 | 6.72 | 6.11 | Upgrade
|
| EV/EBITDA Ratio | 218.04 | 6378.70 | 51.76 | 58.25 | 47.48 | 50.62 | Upgrade
|
| EV/EBIT Ratio | - | - | 143.00 | 161.08 | 78.18 | 88.35 | Upgrade
|
| EV/FCF Ratio | -1586.99 | - | - | 54.59 | - | 95.60 | Upgrade
|
| Debt / Equity Ratio | 0.19 | 0.16 | 0.13 | 0.19 | 0.01 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 8.20 | 31.32 | 2.25 | 3.67 | 0.19 | 0.15 | Upgrade
|
| Debt / FCF Ratio | - | - | - | 3.74 | - | 0.28 | Upgrade
|
| Net Debt / Equity Ratio | -0.14 | -0.13 | -0.13 | -0.18 | -0.46 | -0.52 | Upgrade
|
| Net Debt / EBITDA Ratio | -7.81 | -309.53 | -2.39 | -3.78 | -7.45 | -10.18 | Upgrade
|
| Net Debt / FCF Ratio | 44.40 | 5.36 | 1.83 | -3.54 | 467.03 | -19.23 | Upgrade
|
| Asset Turnover | 0.34 | 0.32 | 0.35 | 0.33 | 0.32 | 0.32 | Upgrade
|
| Inventory Turnover | 1.43 | 1.44 | 1.56 | 1.68 | 1.96 | 2.40 | Upgrade
|
| Quick Ratio | 1.82 | 1.57 | 1.63 | 1.50 | 2.44 | 2.83 | Upgrade
|
| Current Ratio | 2.65 | 2.12 | 2.17 | 1.95 | 2.96 | 3.16 | Upgrade
|
| Return on Equity (ROE) | -17.74% | -19.14% | 3.48% | 2.62% | 5.34% | 3.59% | Upgrade
|
| Return on Assets (ROA) | -0.99% | -1.48% | 0.77% | 0.71% | 1.74% | 1.37% | Upgrade
|
| Return on Invested Capital (ROIC) | -3.22% | -4.45% | 1.98% | 2.14% | 6.52% | 5.04% | Upgrade
|
| Return on Capital Employed (ROCE) | -2.10% | -3.30% | 1.60% | 1.40% | 3.30% | 2.60% | Upgrade
|
| Earnings Yield | -3.78% | -7.37% | 1.18% | 0.85% | 1.50% | 1.12% | Upgrade
|
| FCF Yield | -0.06% | -0.86% | -2.40% | 1.67% | -0.03% | 0.86% | Upgrade
|
| Payout Ratio | - | - | 16.62% | 1.87% | 0.18% | - | Upgrade
|
| Buyback Yield / Dilution | 0.18% | - | - | - | - | 0.02% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.